These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3305243)

  • 41. [Preparation of cerebral ischemia-induced amnesic model in mice and ameliorative effect of several compounds on the model].
    Kojima M; Kaneto H
    Nihon Yakurigaku Zasshi; 1989 Oct; 94(4):223-8. PubMed ID: 2613102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ZTTA, a prolyl endopeptidase inhibitor, on memory impairment in a passive avoidance test of rats with basal forebrain lesions.
    Shishido Y; Furushiro M; Tanabe S; Taniguchi A; Hashimoto S; Yokokura T; Shibata S; Yamamoto T; Watanabe S
    Pharm Res; 1998 Dec; 15(12):1907-10. PubMed ID: 9892477
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative effect of the prolyl endopeptidase inhibitors, benzyloxycarbonyl-prolyl-prolinal and benzyloxycarbonyl-methionyl-cyanopyrrolidine, on the acute exudative inflammation and visceral pain in mice].
    Ivanova EA; Zolotov NN; Voronina TA
    Biomed Khim; 2020 Sep; 66(5):423-426. PubMed ID: 33140738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Y-29794--a non-peptide prolyl endopeptidase inhibitor that can penetrate into the brain.
    Nakajima T; Ono Y; Kato A; Maeda J; Ohe T
    Neurosci Lett; 1992 Jul; 141(2):156-60. PubMed ID: 1436628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolyl endopeptidase: inhibition in vivo by N-benzyloxycarbonyl-prolyl-prolinal.
    Friedman TC; Orlowski M; Wilk S
    J Neurochem; 1984 Jan; 42(1):237-41. PubMed ID: 6358414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of amiridin on ambulatory activity and the discrete shuttle avoidance response in mice].
    Kuribara H
    Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):299-307. PubMed ID: 3792960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ZTTA, a postproline cleaving enzyme inhibitor, improves cerebral ischemia-induced deficits in a three-panel runway task in rats.
    Shishido Y; Furushiro M; Tanabe S; Nishiyama S; Hashimoto S; Ohno M; Yamamoto T; Watanabe S
    Pharmacol Biochem Behav; 1996 Nov; 55(3):333-8. PubMed ID: 8951974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo inhibition of prolyl endopeptidase.
    Atack JR; Suman-Chauhan N; Dawson G; Kulagowski JJ
    Eur J Pharmacol; 1991 Nov; 205(2):157-63. PubMed ID: 1812006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia.
    Zolotov NN; Schepetkin IA; Voronina TA; Pozdnev VF; Khlebnikov AI; Krylova IV; Quinn MT
    Front Chem; 2021; 9():780958. PubMed ID: 35004610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and structure of prolinal-containing peptides, and their use as specific inhibitors of prolyl endopeptidases.
    Nishikata M; Yokosawa H; Ishii S
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2931-6. PubMed ID: 3533287
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of 5-iodouracil and 2,6-diaminopurine on passive avoidance task.
    Reinis S
    Psychopharmacologia; 1971; 19(1):34-9. PubMed ID: 5108765
    [No Abstract]   [Full Text] [Related]  

  • 52. An improved one-trial passive avoidance learning situation.
    Jarvik ME; Kopp R
    Psychol Rep; 1967 Aug; 21(1):221-4. PubMed ID: 6078370
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.
    Toide K; Fujiwara T; Iwamoto Y; Shinoda M; Okamiya K; Kato T
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):355-62. PubMed ID: 8692293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anti-amnesic effect of prolyl endopeptidase inhibitors in mice].
    Nanri M; Kaneto H
    Nihon Yakurigaku Zasshi; 1987 Jun; 89(6):323-9. PubMed ID: 3305244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect.
    Yoshimoto T; Kado K; Matsubara F; Koriyama N; Kaneto H; Tsura D
    J Pharmacobiodyn; 1987 Dec; 10(12):730-5. PubMed ID: 3330562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice.
    Sato T; Ishida T; Irifune M; Tanaka K; Hirate K; Nakamura N; Nishikawa T
    Eur J Pharmacol; 2007 Mar; 560(1):36-41. PubMed ID: 17303115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of vasopressin analog: [d(CH2)(1)5,Tyr(Me)2,delta 3Pro7]AVP on learning and memory processes in rats with experimental amnesia.
    Car H; Borawska M; Wiśniewski K
    Pol J Pharmacol; 1993; 45(1):11-22. PubMed ID: 8401755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of pretraining administration of NC-1900, a vasopressin fragment analog, on memory performance in non- or CO2-amnesic mice.
    Sato T; Tanaka K; Teramoto T; Ohnishi Y; Hirate K; Irifune M; Nishikawa T
    Pharmacol Biochem Behav; 2004 Jun; 78(2):309-17. PubMed ID: 15219772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experimental models for studying the avoidance response in mice and the anti-amnesic effect of prolyl endopeptidase inhibitors].
    Taira K; Kaneto H
    Nihon Yakurigaku Zasshi; 1987 May; 89(5):243-52. PubMed ID: 3305243
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.